Market Tracker

08/27 6:01pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.06
Delayed Data
As of Aug 27
 +0.09 / +9.28%
Today’s Change
0.53
Today|||52-Week Range
1.33
+58.20%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.97
Today’s open0.99
Day’s range0.99 - 1.07
Volume670,392
Average volume (3 months)1,244,940
Market cap$42.9M
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+82.79%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-9.63%
P/E ratio1.9
Price/Sales1.55
Price/Book1.45

Competitors

 Today’s
change
Today’s
% change
--United Gene High-Tec...+0.00+3.33%
HTBXHeat Biologics Inc-0.11-2.08%
GNVCGenVec Inc+0.09+3.77%
BIODBiodel Inc+0.02+3.21%
Data as of 3:59pm ET, 08/27/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.2M
Annual profit (last year)$28.8M
Net profit margin92.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts